Table.

Characteristics of 15 critically ill patients with COVID-19 who received corticosteroids

No	Age (yr)	Sex	Time from symptoms to steroids (days)	Steroid administered	Dosage of steroid over first 24 hr – Methylprednisolone equivalents (mg)	Indication	Clinical change 24 hr post therapy	CRP (mg L−1)	PaO2/FIO2 ratio	Current condition
1	72	M	12	Methylprednisolone	160	Vasoplegia	Improved hemodynamics	348→163	N/A	Ward
2	72	M	16	Methylprednisolone	160	Severe ARDS	Moderate ARDS	341→9	73→130	ICU
3	62	M	10	Hydrocortisone	40	Severe ARDS	Moderate ARDS	455→217	77→150	Ward
4	66	M	14	Methylprednisolone	160	Severe ARDS	Severe ARDS	378→121	71→77	Deceased
5	53	F	8	Methylprednisolone	160	Severe ARDS	Moderate ARDS	466→150	92→100	ICU
6	63	F	14	Hydrocortisone	60	Severe ARDS & vasoplegia	Moderate ARDS and improved hemodynamics	556→49	83→110	ICU
7	66	M	16	Hydrocortisone	60	Vasoplegia	Improved hemodynamics	293→85	N/A	ICU
8	78	M	13	Methylprednisolone	160	Severe ARDS & vasoplegia	Moderate ARDS and improved hemodynamics	425→149	60→110	Deceased
9	55	M	14	Dexamethasone	106.7	5L NP	1L NP	210→61	N/A	Home
10	74	M	13	Dexamethasone	106.7	5L NP	4L NP	297→104	N/A	Home
11	72	F	14	Methylprednisolone	160	Severe ARDS	Moderate ARDS	115→48	87→155	Home
12	75	M	12	Hydrocortisone	40	Vasoplegia	Improved hemodynamics	N/A	N/A	Deceased
13	45	F	12	Methylprednisolone	160	Severe ARDS	Moderate ARDS	80→22	82→145	Home
14	75	F	22	Methylprednisolone	120	Severe ARDS	Severe ARDS	N/A	81→81	Ward
15	73	F	17	Methylprednisolone	160	Severe ARDS	Moderate ARDS	368→87	94→183	Ward

Severe ARDS defined as PaO2/F_IO2 ratio < 100, Moderate ARDS defined as PaO₂/F_IO₂ ratio ≥ 100 and < 200. ARDS = acute respiratory distress syndrome; COVID-19 = coronavirus disease; CRP = C-reactive protein; ICU = intensive care unit; N/A = not available; NP = nasal prongs; PaO₂/F_IO₂ = arterial partial pressure of oxygen/fraction of inspired oxygen.